GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...
Expanded testing panel provides a better understanding of a patient’s genetic medication risk profile. Genomind’s real-time, interactive, medication management tool GenMedPro™ has expanded to include ...
PHILADELPHIA--(BUSINESS WIRE)-- Audacy announced a multiplatform partnership with mental health innovator Genomind. This breakthrough partnership taps into Audacy’s influencers and Genomind’s ...
Genomind’s pharmacogenetic testing, which is transforming the landscape of precision medicine, uses a simple cheek swab to assess genes that influence drug metabolism, tolerability, and efficacy. The ...
MOORESTOWN, N.J.--(BUSINESS WIRE)--Cosán, a provider of technology-driven preventative care services for older adults and the physicians that support them, and Genomind, a leading precision healthcare ...
Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development GLEN ALLEN, Va., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback